Cryostat Microtome Equipment Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Cryostat Microtome Equipment Market is segmented By Product Type (Manual microtome cryostat equipment, Semi-automatic microtome cryostat equipment, Automatic cryostat microtome equipment), By Sample Type (Plant Tissue, Animal Tissue, Others), By Application (Biology, Medicine, Industrial, Others), By End-user (Ambulatory Surgical Centers, Diagnostic & Research Laboratories, Hospitals, Others), By Region (North America, South America, Europe, Asia Pacific, Middle East & Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Market Report

Cryostat Microtome Equipment Market is estimated to reach at a high CAGR during the forecast period (2023-2030).

A cryostat microtome, a freezing microtome, is a piece of medical equipment used to generate cryo-sections of plant and animal tissues into thin sections. Microtome cryostats are used in various medicinal, biological, and industrial applications. A microtome cryostat is a refrigerated cabinet containing a microtome that is normally operated at temperatures ranging from -5°C to -50°C. It consists of a sectioning device, a rotary microtome, a blade holder or knife, and a mechanism to freeze the samples.

Cryostat Microtome Equipment Market Scope

For More Insights Request Free Sample

Cryostat Microtome Equipment Market Dynamics

The increasing use of cryostat-microtomes in immunohistochemistry laboratories to find cancer markers is expected to drive market growth.

Immunohistochemistry (IHC) is a branch of biology that uses antibodies to identify antigens (proteins) in tissue slices. A classic application is the biopsy of tissue samples to find cancer markers. A freezing temperature chamber is the only means to achieve fine slices, which are necessary for immunohistochemistry applications (while sectioning the tissue sample). Tissue samples are too delicate to cut into thin sections without this type of chamber. This cool chamber protects the sample from thawing while sectioning, as well as reduces microbial damage to the tissue sample. When findings are expected immediately, and the antigenicity of delicate molecules must be retained, this cryo-section is vitally necessary. These materials are processed in an IHC laboratory in a cryostat with a microtome. A microtome is a device that cuts thin tissue pieces for study. Cryo-sections are thin slices generated by the cryostat that is then examined under a microscope. These ultra-thin slices allow scientists to make a more accurate judgment about the nature of a disease in a shorter amount of time. Therefore, cryostats make a substantial contribution to the healthcare business. A tiny tissue piece from the patient is frequently analyzed to determine the next course of treatment. In cases of diseases such as cancer, treatment cannot resume until the immunocytochemistry lab returns the results of a tissue biopsy. As a result, the diagnosis must be completed as soon as possible using techniques involving the cryostat-microtome. Thus, from the above statements, the market is expected to drive market growth.

Restraint

The high cost associated with the cryostat microtome equipment and the lack of skilled professionals to operate cryostat microtome equipment are the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The cryostat microtome equipment market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. All outpatient treatments were postponed or limited during the COVID-19 pandemic because most chronic therapies were seen as non-urgent to reduce the risk of viral transmission. For the study of tissue histopathology, cryostat microtome equipment is frequently employed in diagnostic and research laboratories. In addition, as the pandemic spread, the market for cryostat microtome equipment has benefited from an increased study into the immunohistochemistry of COVID-19-infected tissues. In contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Cryostat Microtome Equipment Market Segment Analysis

Automatic cryostat microtome equipment segment is expected to hold the largest market share in cryostat microtome equipment market

The automatic cryostat microtome equipment segment accounted for the largest market share in 2021. The segment benefits because tissue sectioning automation can provide labs with faster setup and alignment, programmable settings, speedier sectioning, and motorized trimming. This makes it possible for histopathologists to process more sample blocks in a shorter time, leading to faster patient diagnosis. Saving time allows for processing more samples and using pathologists' output by allowing them to work on different aspects of tissue processing simultaneously. Moreover, automated microtomes can also be used for quality assurance. Engineers and producers know the impact human error and weariness can have on the quality of produced portions. The motorized feed can produce the same velocity each time to cut continuous sections of the same quality for thicker sections and harder specimens, including malignant tissue, calcified tissue, and decalcified teeth. For instance, an innovative, precise specimen feeding mechanism called the Minux Rotary Paraffin Microtomes (Semi-Auto / Fully Auto) perfectly enables microtomists to get outstanding, thin serial section results. A patented visible pointer helps you position sections quickly and precisely. It is frequently employed in anatomical pathology and histopathology. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Cryostat Microtome Equipment Market Geographical Share

North America region holds the largest market share in the global cryostat microtome equipment market

North America accounted for the largest market share in 2021. The increasing prevalence of cancer, technological advancements in immunohistochemistry research studies, and increasing adoption of highly advanced techniques in cryostat microtome equipment, product launches, and acquisitions by the key market players are some factors the market is driven in the forecast period. For instance, according to the American Cancer Society, in 2020, an estimated 1.8 million new cancer cases and 606,520 cancer deaths in the United States will be diagnosed. In contrast, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Therefore, it has increased the adoption of cryostat microtome equipment. Moreover, Precisionary Instruments LLC announced the release of a new precision cryostat in April 2020. (Model CF-6100). In pathology, dermatology, and histology labs, the CF-6100 cryostat is a high-precision microtome with dual compressors, UV light disinfection, and an LED touchscreen control panel that encourages and supports high-quality tissue sectioning. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Cryostat Microtome Equipment Market Keyplayers

Major key players in the cryostat microtome equipment market are Amos Scientific Pty Ltd, Avantor, Inc., Thermo Fisher Scientific Inc., Leica Biosystems Nussloch GmbH, Bright Instruments Ltd, Freezers India, Medimeas, SM Scientific Instruments Pvt. Ltd. India, SLEE medical GmbH andTanner Scientific, Inc.

Amos Scientific Pty Ltd:

Overview:

Amos Scientific Pty Ltd is a medical research company specializing in human tissue research. Amos Scientific was founded in Melbourne, Australia, and has been responsible for manufacturing pioneering devices such as the microtome, cryostat microtome, embedding center system, vacuum tissue processor, and immunohisto stainer. The company has established a strong R&D team to maintain a leading edge and develop automatic and digital diagnoses in histology. Moreover, the company's engineers launched high-tech products in the global medical industry, such as an automatic microtome post-processing system and an automatic liquid-based cytology slide staining system in 2013.

­Product Portfolio:

AST500 Semi-automatic microtome cryostat equipment: The AST 500 is a semi-automatic cryostat microtome with forwarding and backward movement motorized specimens. As a result, it can obtain a high-quality part that is also simple to work with. It is developed with an overall engineering and ergonomic philosophy in mind. A computer numerically controlled machine processes all of the components. The retraction feature protects the specimen from blade damage. Calculate the total thickness. Low-temperature refrigeration system using the environmentally beneficial refrigerant R404. Every time, use UV and O3 sterilization for 30 minutes. Peltier specimen clamp refrigeration can be manually turned on and off. There are two types of defrosting methods: automatic and manual. The high-precision unit is contained outside the cryostat chamber to avoid thermal expansion and contraction and to keep maintenance to a minimum. The artificial intelligent interface is simple to learn and operate.

The global cryostat microtome equipment market report would provide an access to an approx. 45+market data table, 40+figures, and 180pages.